---
{"dg-publish":true,"permalink":"/research/tags/intervertebral-disc-ivd/","updated":"2025-01-30T16:16:10-05:00"}
---

# Tagged Content
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Takeaways</span><span class="dataview small-text">4</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-30 12-16-01.md" data-href="Research/Takeaways/2025-01-30 12-16-01.md" href="Research/Takeaways/2025-01-30 12-16-01.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-16-01</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Back Pain" href="Back Pain" class="internal-link" target="_blank" rel="noopener nofollow">Back Pain</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a> can be reduced within 3 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-28 20-17-29.md" data-href="Research/Takeaways/2025-01-28 20-17-29.md" href="Research/Takeaways/2025-01-28 20-17-29.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 20-17-29</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> height is not changed within 12 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-28 20-16-12.md" data-href="Research/Takeaways/2025-01-28 20-16-12.md" href="Research/Takeaways/2025-01-28 20-16-12.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 20-16-12</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> hydration can be increased within 12 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-28 20-12-29.md" data-href="Research/Takeaways/2025-01-28 20-12-29.md" href="Research/Takeaways/2025-01-28 20-12-29.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 20-12-29</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> dose of at least 4 mg/kg/day may reduce the progression of <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Insights</span><span class="dataview small-text">33</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-37-02.md" data-href="Research/Insights/2025-01-30 15-37-02.md" href="Research/Insights/2025-01-30 15-37-02.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-37-02</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the reduction in <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> histological score at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-35-56.md" data-href="Research/Insights/2025-01-30 15-35-56.md" href="Research/Insights/2025-01-30 15-35-56.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-35-56</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progressive loss of <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> height at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 12 weeks of age compared to rats not fed Urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-34-35.md" data-href="Research/Insights/2025-01-30 15-34-35.md" href="Research/Insights/2025-01-30 15-34-35.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-34-35</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progression of <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-34-20.md" data-href="Research/Insights/2025-01-30 15-34-20.md" href="Research/Insights/2025-01-30 15-34-20.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-34-20</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progression of <a data-href="Pfirrmann Grade" href="Pfirrmann Grade" class="internal-link" target="_blank" rel="noopener nofollow">Pfirrmann Grade</a> at a dose of 25 mg/kg/day when taken for 4 weeks after an <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> puncture at 12 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-33-56.md" data-href="Research/Insights/2025-01-30 15-33-56.md" href="Research/Insights/2025-01-30 15-33-56.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-33-56</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progression of <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 12 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-32-27.md" data-href="Research/Insights/2025-01-30 15-32-27.md" href="Research/Insights/2025-01-30 15-32-27.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-32-27</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progression in <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> <a data-href="Pfirrmann Grade" href="Pfirrmann Grade" class="internal-link" target="_blank" rel="noopener nofollow">Pfirrmann Grade</a> at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-31-32.md" data-href="Research/Insights/2025-01-30 15-31-32.md" href="Research/Insights/2025-01-30 15-31-32.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-31-32</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the increase in histologic score at a dose of 25 mg/kg/day when taken for 4 weeks after an <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> puncture at 12 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-28-05.md" data-href="Research/Insights/2025-01-30 15-28-05.md" href="Research/Insights/2025-01-30 15-28-05.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-28-05</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> reduces the number of TUNEL-positive cells in the <a data-href="Nucleus Pulposus" href="Nucleus Pulposus" class="internal-link" target="_blank" rel="noopener nofollow">Nucleus Pulposus</a> at a dose of 25 mg/kg/day when taken for 4 weeks after an <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> puncture at 8 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-25-18.md" data-href="Research/Insights/2025-01-30 15-25-18.md" href="Research/Insights/2025-01-30 15-25-18.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-25-18</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> reduces the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> histological score at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-24-17.md" data-href="Research/Insights/2025-01-30 15-24-17.md" href="Research/Insights/2025-01-30 15-24-17.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-24-17</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> reduces the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> <a data-href="Pfirrmann Grade" href="Pfirrmann Grade" class="internal-link" target="_blank" rel="noopener nofollow">Pfirrmann Grade</a> at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-17-08.md" data-href="Research/Insights/2025-01-30 15-17-08.md" href="Research/Insights/2025-01-30 15-17-08.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-17-08</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> increases the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> disc height index at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-15-20.md" data-href="Research/Insights/2025-01-30 15-15-20.md" href="Research/Insights/2025-01-30 15-15-20.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-15-20</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> increases the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> <a data-href="Collagen Type II" href="Collagen Type II" class="internal-link" target="_blank" rel="noopener nofollow">Collagen Type II</a> fluorescence at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-14-32.md" data-href="Research/Insights/2025-01-30 15-14-32.md" href="Research/Insights/2025-01-30 15-14-32.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-14-32</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> increases the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> <a data-href="Aggrecan" href="Aggrecan" class="internal-link" target="_blank" rel="noopener nofollow">Aggrecan</a> fluorescence at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15 28 41.md" data-href="Research/Insights/2025-01-30 15 28 41.md" href="Research/Insights/2025-01-30 15 28 41.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15 28 41</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> reduces the progression of <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 14-48-20.md" data-href="Research/Insights/2025-01-30 14-48-20.md" href="Research/Insights/2025-01-30 14-48-20.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 14-48-20</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The number of <a data-href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> injected into the <a data-href="Annulus Fibrosus" href="Annulus Fibrosus" class="internal-link" target="_blank" rel="noopener nofollow">Annulus Fibrosus</a> of a torn <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a> <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> may positively correlate with overall improvement in quality of life after 4+ years</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 14-29-17.md" data-href="Research/Insights/2025-01-30 14-29-17.md" href="Research/Insights/2025-01-30 14-29-17.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 14-29-17</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The ideal single dose for injecting <a data-href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into the <a data-href="Annulus Fibrosus" href="Annulus Fibrosus" class="internal-link" target="_blank" rel="noopener nofollow">Annulus Fibrosus</a> of a torn <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a> <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> to improve overall quality of life after 4+ years may be 35.9 million cells</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 14-13-16.md" data-href="Research/Insights/2025-01-30 14-13-16.md" href="Research/Insights/2025-01-30 14-13-16.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 14-13-16</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Sciatica" href="Sciatica" class="internal-link" target="_blank" rel="noopener nofollow">Sciatica</a> is reduced by an average of 86% at 12 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 14-12-07.md" data-href="Research/Insights/2025-01-30 14-12-07.md" href="Research/Insights/2025-01-30 14-12-07.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 14-12-07</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Sciatica" href="Sciatica" class="internal-link" target="_blank" rel="noopener nofollow">Sciatica</a> is reduced by an average of 79% at 6 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 14-08-07.md" data-href="Research/Insights/2025-01-30 14-08-07.md" href="Research/Insights/2025-01-30 14-08-07.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 14-08-07</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Sciatica" href="Sciatica" class="internal-link" target="_blank" rel="noopener nofollow">Sciatica</a> is not significantly reduced at 3 months after after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 14-02-08.md" data-href="Research/Insights/2025-01-30 14-02-08.md" href="Research/Insights/2025-01-30 14-02-08.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 14-02-08</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Neuropathy" href="Neuropathy" class="internal-link" target="_blank" rel="noopener nofollow">Neuropathy</a> and/or <a data-href="Chemical Radiculitis" href="Chemical Radiculitis" class="internal-link" target="_blank" rel="noopener nofollow">Chemical Radiculitis</a> can be resolved within 12 weeks of injecting 10X <a data-href="Platelet-Rich Plasma (PRP)" href="Platelet-Rich Plasma (PRP)" class="internal-link" target="_blank" rel="noopener nofollow">Platelet-Rich Plasma (PRP)</a> into the <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-15-27.md" data-href="Research/Insights/2025-01-30 12-15-27.md" href="Research/Insights/2025-01-30 12-15-27.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-15-27</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Back Pain" href="Back Pain" class="internal-link" target="_blank" rel="noopener nofollow">Back Pain</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a> is reduced by an average of 71% at 12 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-13-47.md" data-href="Research/Insights/2025-01-30 12-13-47.md" href="Research/Insights/2025-01-30 12-13-47.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-13-47</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Back Pain" href="Back Pain" class="internal-link" target="_blank" rel="noopener nofollow">Back Pain</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a> is reduced by an average of 69% at 6 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-11-56.md" data-href="Research/Insights/2025-01-30 12-11-56.md" href="Research/Insights/2025-01-30 12-11-56.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-11-56</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Back Pain" href="Back Pain" class="internal-link" target="_blank" rel="noopener nofollow">Back Pain</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a> is reduced by an average of 62% at 3 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-06-46.md" data-href="Research/Insights/2025-01-30 12-06-46.md" href="Research/Insights/2025-01-30 12-06-46.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-06-46</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Injecting leukocyte-rich &gt;10X <a data-href="Platelet-Rich Plasma (PRP)" href="Platelet-Rich Plasma (PRP)" class="internal-link" target="_blank" rel="noopener nofollow">Platelet-Rich Plasma (PRP)</a> into a pain-generating <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> is successful in 70% of patients as assessed by NRS pain score, FRI, and patient satisfaction</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-54-58.md" data-href="Research/Insights/2025-01-29 10-54-58.md" href="Research/Insights/2025-01-29 10-54-58.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-54-58</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> hydration is increased by an average of 16% at 12 months after intradiscal injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-55-56.md" data-href="Research/Insights/2025-01-29 10-55-56.md" href="Research/Insights/2025-01-29 10-55-56.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-55-56</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Discopathy" href="Discopathy" class="internal-link" target="_blank" rel="noopener nofollow">Discopathy</a> should be the term used to collectively refer to <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> bulges and disc protrusions and discs with normal contours but abnormal heights and-or T2 signal intensities on <a data-href="Magnetic Resonance Imaging (MRI)" href="Magnetic Resonance Imaging (MRI)" class="internal-link" target="_blank" rel="noopener nofollow">Magnetic Resonance Imaging (MRI)</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-53-58.md" data-href="Research/Insights/2025-01-29 10-53-58.md" href="Research/Insights/2025-01-29 10-53-58.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-53-58</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> bulges, disc protrusions, and discs with normal contours but abnormal heights and-or T2 signal intensities on <a data-href="Magnetic Resonance Imaging (MRI)" href="Magnetic Resonance Imaging (MRI)" class="internal-link" target="_blank" rel="noopener nofollow">Magnetic Resonance Imaging (MRI)</a> are highly likely to indicate the presence of a tear in the inner <a data-href="Annulus Fibrosus" href="Annulus Fibrosus" class="internal-link" target="_blank" rel="noopener nofollow">Annulus Fibrosus</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-52-14.md" data-href="Research/Insights/2025-01-29 10-52-14.md" href="Research/Insights/2025-01-29 10-52-14.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-52-14</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> height is not changed at 12 months after intradiscal injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-39-27.md" data-href="Research/Insights/2025-01-29 10-39-27.md" href="Research/Insights/2025-01-29 10-39-27.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-39-27</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A reduction in posterior <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> bulge size by &gt;= 25% correlates with better NPS scores compared with &lt;25% at 6 months post-injection of an average of 23 million <a data-href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into the <a data-href="Nucleus Pulposus" href="Nucleus Pulposus" class="internal-link" target="_blank" rel="noopener nofollow">Nucleus Pulposus</a> and <a data-href="Annulus Fibrosus" href="Annulus Fibrosus" class="internal-link" target="_blank" rel="noopener nofollow">Annulus Fibrosus</a> of <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a> or <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-27-22.md" data-href="Research/Insights/2025-01-29 10-27-22.md" href="Research/Insights/2025-01-29 10-27-22.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-27-22</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>85% of patients have a decrease in posterior <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> bulge size 6 months on average post-injection of an average of 23 million <a data-href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into the <a data-href="Nucleus Pulposus" href="Nucleus Pulposus" class="internal-link" target="_blank" rel="noopener nofollow">Nucleus Pulposus</a> and <a data-href="Annulus Fibrosus" href="Annulus Fibrosus" class="internal-link" target="_blank" rel="noopener nofollow">Annulus Fibrosus</a> of <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a> or <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-20-44.md" data-href="Research/Insights/2025-01-29 10-20-44.md" href="Research/Insights/2025-01-29 10-20-44.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-20-44</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>34% of people between 20-39 have an asymptomatic degenerated <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> of the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-19-30.md" data-href="Research/Insights/2025-01-29 10-19-30.md" href="Research/Insights/2025-01-29 10-19-30.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-19-30</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>21% of people between 20-39 have an asymptomatic herniated <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-17-29.md" data-href="Research/Insights/2025-01-29 10-17-29.md" href="Research/Insights/2025-01-29 10-17-29.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-17-29</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>56% of people between 20-39 have an asymptomatic bulging <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> of the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a></span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Quick Notes</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-28 19-04-29.md" data-href="Research/Quick Notes/2025-01-28 19-04-29.md" href="Research/Quick Notes/2025-01-28 19-04-29.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 19-04-29</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Forskolin" href="Forskolin" class="internal-link" target="_blank" rel="noopener nofollow">Forskolin</a> inhibits the progression of <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Assumptions</span><span class="dataview small-text">6</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-29 09-37-15.md" data-href="Research/Assumptions/2025-01-29 09-37-15.md" href="Research/Assumptions/2025-01-29 09-37-15.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 09-37-15</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The results for lutzClinicalOutcomesFollowing2022 can be extrapolated to all <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> issues</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-25-18.md" data-href="Research/Assumptions/2025-01-28 21-25-18.md" href="Research/Assumptions/2025-01-28 21-25-18.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-25-18</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The methods used to assess <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> hydration in orozcoIntervertebralDiscRepair2011 are valid</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-20-02.md" data-href="Research/Assumptions/2025-01-28 21-20-02.md" href="Research/Assumptions/2025-01-28 21-20-02.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-20-02</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The effect of <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> on <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration in response to IVD puncture is the same for rats of all ages</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-03-50.md" data-href="Research/Assumptions/2025-01-28 21-03-50.md" href="Research/Assumptions/2025-01-28 21-03-50.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-03-50</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration progresses similarly between rats and humans</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-02-30.md" data-href="Research/Assumptions/2025-01-28 21-02-30.md" href="Research/Assumptions/2025-01-28 21-02-30.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-02-30</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> degeneration progresses similarly amongst rats of all ages in response to a puncture model</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 20-53-52.md" data-href="Research/Assumptions/2025-01-28 20-53-52.md" href="Research/Assumptions/2025-01-28 20-53-52.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 20-53-52</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>An <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> puncture is an appropriate model for assessing IVD degeneration in rats</span></td></tr></tbody></table></div>

